trending Market Intelligence /marketintelligence/en/news-insights/trending/OsjvY4TIwzfjwSYT0wv6Rw2 content esgSubNav
In This List

AK Medical to launch Hong Kong IPO


Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection


Japan M&A By the Numbers: Q4 2023


Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

AK Medical to launch Hong Kong IPO

AK Medical Holdings Ltd. is listing its shares on the Hong Kong Stock Exchange and expects to raise up to HK$500 million from the IPO.

The China-based medical device maker is offering up to 250 million shares, comprising an initial Hong Kong public offering of 25 million shares and an initial international placing of 225 million shares. The shares have a nominal value of 1 Hong Kong cent apiece.

The shares will be priced at between HK$1.66 and HK$2 each.

The issue includes an overallotment option of 37.5 million shares, equivalent to about 15% of the total shares in the offering.

The company will use net proceeds from the offering to construct facilities in Changzhou, China, to develop and upgrade the company's 3D-printed products, for research and development activities, for potential M&A and strategic alliances and for general corporate purposes.

Trading in the company's shares is expected to commence at 9 a.m. Hong Kong time on Dec. 20.

In September, HealthInvestor Asia reported that the company had refiled plans for the IPO.

Goldman Sachs (Asia) LLC is the sole sponsor, global coordinator and book runner in the offering. Guotai Junan Securities (Hong Kong) Ltd. serves as joint lead manager, along with Goldman Sachs.